Catinazzo Thomas bought RLAY
June 22, 2026 · Form 4 insider transaction
Catinazzo Thomas bought 51,560 shares of Relay Therapeutics, Inc. at $4.45 per share, a transaction worth $229.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,560
Price
$4.45
Total value
$229.4K
InsiderCatinazzo Thomas
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after229,021
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.; Includes 9,807 shares underlying restricted stock units.